Astrantus »

Teladoc shares owned by Astrantus

Quarter-by-quarter ownership of Teladoc (TDOC) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Teladoc

Tip: Access up to 7 years of quarterly data

All positions including Teladoc held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teladoc by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $368k 5.1k 72.16
2021-12-31 $340k 3.7k 91.89

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Teladoc

BlackRock
Vanguard Group
Point72 Asset Management
Goldman Sachs Group
Renaissance Technologies
State Street Corporation
Rubric Capital Management
Geode Capital Management
Dimensional Fund Advisors
Wellington Management Company
Voloridge Investment Management
Charles Schwab Investment Management
Pale Fire Capital SE
Barclays
Citadel Advisors

View all funds holding Teladoc